Special Populations (SPO)

P-051 - PILOT ON HARMONIZING DOSING RECOMMENDATIONS FOR TERM AND PRETERM NEONATES IN THE NETHERLANDS (NEODOSE PROJECT).

P-092 - MODEL-INFORMED EXTRAPOLATION APPROACH TO SUPPORT THE APPROVAL OF INTRAVENOUS GOLIMUMAB FOR POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS AND JUVENILE PSORIATIC ARTHRITIS.

P-112 - IS LESS MORE? – DEVELOPMENT OF A DEPRESCRIBING MANUAL FOR THE COFRAIL STUDY.

P-113 - UPDATING THE GERMAN PRISCUS LIST OF POTENTIALLY INAPPROPRIATE MEDICATION – PRISCUS 2.0.

P-138 - CYP2C19 EXPRESSION IS DOWN-REGULATED IN ADVANCED FIBROSIS OR HISTOLOGICALLY SEVERE NON-ALCOHOLIC FATTY LIVER DISEASE.

P-142 - CARDIOMETABOLIC GENOMICS AND PHARMACOGENOMICS INVESTIGATIONS IN FILIPINO AMERICANS: STEPS TOWARDS PRECISION HEALTH AND REDUCING HEALTH DISPARITIES.

P-168 - GENETIC AND SEASONAL DETERMINANTS OF VITAMIN D STATUS IN CONFEDERATED SALISH AND KOOTENAI TRIBES (CSKT) PARTICIPANTS.

P-170 - PHARMACOMETABOLOMICS PROFILING OF PRETERM INFANTS VALIDATES PATTERNS OF METABOLISM ASSOCIATED WITH RESPONSE TO DEXAMETHASONE TREATMENT FOR BRONCHOPULMONARY DYSPLASIA.

PT-007 - OPTIMIZING DIHYDROARTEMISININ-PIPERAQUINE REGIMENS FOR MALARIA PREVENTION IN PREGNANT WOMEN USING REPEATED ECG AND PARASITE DENSITY MEASURES.

PT-007 - OPTIMIZING DIHYDROARTEMISININ-PIPERAQUINE REGIMENS FOR MALARIA PREVENTION IN PREGNANT WOMEN USING REPEATED ECG AND PARASITE DENSITY MEASURES.

PW-007 - OFF-LABEL, BUT ON EVIDENCE? THE LEVEL OF EVIDENCE OF PEDIATRIC PHARMACOTHERAPY.

PW-009 - AN EXPLORATION OF FACTORS THAT MAY INFLUENCE RACIAL AND ETHNIC DIVERSITY IN CLINICAL TRIAL POPULATIONS IN THE FOOD AND DRUG ADMINISTRATION’S (FDA) DRUG TRIALS SNAPSHOTS.